Protalix BioTherapeutics, Inc. (PLX) — Institutional Holders, Q2 2026 (page 2)
102 institutional investment managers reported a PLX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $33.7M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 102. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
PLX 13F holders ranked 101–102 of 102
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 101 | SBI Securities , Ltd.#101 · 1 sh | 1 | $2.00 | — | 0.0% |
| 102 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#102 · 1,020 sh | 1,020 | — | — | -73.9% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.